scholarly journals Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results

2007 ◽  
Vol 34 (6) ◽  
pp. 702-708 ◽  
Author(s):  
M. Ferreira ◽  
L. Lanziotti ◽  
M. Monteiro ◽  
G. Abuhadba ◽  
L.F. Capotorto ◽  
...  
1999 ◽  
Vol 6 (3) ◽  
pp. 270-277 ◽  
Author(s):  
Julio A. Rodriguez-Lopez ◽  
Liliana Soler ◽  
Alan Werner ◽  
Edgar Martinez ◽  
Konstantine Papazoglou ◽  
...  

1999 ◽  
Vol 6 (3) ◽  
pp. 270-277 ◽  
Author(s):  
Julio A. Rodriguez-Lopez ◽  
Liliana Soler ◽  
Alan Werner ◽  
Edgar Martinez ◽  
Konstantine Papazoglou ◽  
...  

1993 ◽  
Vol 17 (1) ◽  
pp. 172-182 ◽  
Author(s):  
Robert J. Lusby ◽  
Geoffrey S. Cox ◽  
Norman R. Hertzer ◽  
Jess R. Young ◽  
Patrick J. O'Hara ◽  
...  

1993 ◽  
Vol 17 (1) ◽  
pp. 172-182 ◽  
Author(s):  
Geoffrey S. Cox ◽  
Norman R. Hertzer ◽  
Jess R. Young ◽  
Patrick J. O'Hara ◽  
Leonard P. Krajewski ◽  
...  

2008 ◽  
Vol 23 (4) ◽  
pp. 264-270 ◽  
Author(s):  
Yoshio Sasaki ◽  
Myung-Woo Hwang ◽  
Kuniyuki Shirasawa ◽  
Shinichi Takeda ◽  
Hiroyuki Ayukawa ◽  
...  

Angiology ◽  
2008 ◽  
Vol 60 (1) ◽  
pp. 31-35 ◽  
Author(s):  
Johannes Ruef

For treatment of complex superficial femoral artery lesions, suitable stent devices are required. The present study details the first long-term results with the long EverFlex nitinol stent. Forty-one EverFlex stents were implanted in 32 patients with either superficial femoral artery occlusions (n = 20) or stenoses (n = 12); mean lesion length was 13.3 cm (range = 8.0–39.0). Patients presented with clinical stage Fontaine IIb (n = 27), III (n = 4), or IV (n = 1). Stent lengths were 10 cm (n = 18), 12 cm (n = 6), or 15 cm (n = 17). Follow-up after 2 months indicated primary and secondary patency rates of 96.9% (n = 31) and 100% (n = 32); ABI improved from 0.57 to 0.91 ( P < .001). After 1 year, revascularization was performed in 6 patients (18.8%). Primary and secondary patency rates were 81.3% (n = 26) and 93.8% (n = 30). In this first long-term evaluation, the long EverFlex nitinol stent achieves excellent clinical results after implantation into complex superficial femoral artery lesions.


2008 ◽  
Vol 17 (1) ◽  
pp. 34-42 ◽  
Author(s):  
José M. Carreira ◽  
Ricardo Reyes ◽  
Francisco Gude ◽  
ElÍas Górriz ◽  
Laura Gallardo ◽  
...  

2021 ◽  
Vol 9 ◽  
Author(s):  
Diandong Jiang ◽  
Jianjun Zhang ◽  
Youfei Fan ◽  
Bo Han ◽  
Lijian Zhao ◽  
...  

Objective: The aim of this study was to assess the efficacy and safety of transcatheter retrograde closure of perimembranous ventricular septal defect (pmVSD) via the femoral artery with an Amplatzer Duct Occluder II (ADO II) in children.Methods: The clinical and follow-up data of 102 children who had successfully undergone transcatheter retrograde closure of pmVSD via the femoral artery with Amplatzer Duct Occluder II (ADO II) from February 2012 to June 2019 in our center were retrospectively reviewed.Results: In 102 of 103 patients, the defects were successfully closed (99.0%). The average age was 4.03 ± 1.84 years and the mean weight was 17.50 ± 5.58 kg. The mean diameter of the defects was 2.58 ± 0.63 mm. Hundred of the occluders had a waist length of 4 mm. The complete closure rate was 89.2% 24 h after the procedure and 98% at the last follow-up. The follow-up period ranged from 6 to 92 months, with a median of 36 months. One child developed new mild aortic regurgitation (AR), and 9 patients developed new mild tricuspid regurgitation (TR). During follow-up, TR disappeared in 5 patients and decreased in 4 patients, and AR relieved in one patient. One patient developed intermittent complete left bundle branch block 4 days after the procedure and recovered sinus rhythm 2 days later. No serious complications occurred.Conclusion: Transcatheter retrograde closure of pmVSD via the femoral artery with ADO II in children is safe, feasible, and effective in selected patients.


Sign in / Sign up

Export Citation Format

Share Document